Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Brand-Generic Pay-For-Delay Deals May Become Extinct, FTC Finds
May 23 2019
•
By
Brenda Sandburg
Will pay-for-delay deals between brand and generic companies go the way of T. Rex? • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Generics
More from Biosimilars & Generics